These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene. Watanabe T; Sugauchi F; Tanaka Y; Matsuura K; Yatsuhashi H; Murakami S; Iijima S; Iio E; Sugiyama M; Shimada T; Kakuni M; Kohara M; Mizokami M Gut; 2013 Sep; 62(9):1340-6. PubMed ID: 23135762 [TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice. van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492 [TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. Cheney IW; Lai VC; Zhong W; Brodhag T; Dempsey S; Lim C; Hong Z; Lau JY; Tam RC J Virol; 2002 Nov; 76(21):11148-54. PubMed ID: 12368359 [TBL] [Abstract][Full Text] [Related]
29. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8. Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587 [TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779 [TBL] [Abstract][Full Text] [Related]
31. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro. Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis E virus persists in the presence of a type III interferon response. Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073 [TBL] [Abstract][Full Text] [Related]
33. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
34. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication. Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587 [TBL] [Abstract][Full Text] [Related]
35. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication. Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689 [TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921 [TBL] [Abstract][Full Text] [Related]
37. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner. Sooryanarain H; Heffron CL; Meng XJ mBio; 2020 Jan; 11(1):. PubMed ID: 31937650 [TBL] [Abstract][Full Text] [Related]